CSL Limited SWOT and PESTLE Analysis

ID : 52919753| Nov 2023| 23 pages

COMPANY PROFILE -CSL Limited (Commonwealth Serum Laboratories)

Business Sector :Biotechnology

Operating Geography :Australia, Global

About CSL Limited (Commonwealth Serum Laboratories) :

CSL - Commonwealth Serum Laboratories, is a specialty biotechnology company operating globally. It researches, develops, manufactures, and then markets products that are used to treat and prevent serious human medical conditions. It was established in 1916 in Australia to serve the health needs of a nation isolated by war. But over the years CSL has kept innovating and provided Australians with access to advanced medical services, some of which include insulin, penicillin, and vaccines against influenza, polio, and other infectious diseases. CSL Limited was incorporated in 1991 and was listed in 1994. The major product area of CSL includes blood plasma derivatives, vaccines, antivenoms, and cell culture reagents used in research and manufacturing applications. It has its headquarters in Melbourne, Australia, and provides life-saving medicines to more than 100 nations. CSL has also acquired several companies. Decades of research, investigation, innovation, and experience make CSL the global innovative leader. As of 2023, it employed more than 30,000 employees globally.
Innovation is the core of CSL and remains its USP. It enjoys a reputation as a passionate yet responsible organization driven to care for patients and deliver on its commitments. CSL’s mission reads “Driven by Our Promise”. Its values include “Patient Focus”, “Innovation”, “Integrity”, “Collaboration” and “Superior Performance”.

CSL Limited (Commonwealth Serum Laboratories) Revenue :

$13,310 million – FY ending 30th June 2023 (y-o-y growth of 26%)
$10,562 million – FY ending 30th June 2022

Competitive Analysis of CSL Limited (Commonwealth Serum Laboratories)

SWOT

PESTLE

The SWOT analysis for CSL Limited is presented below in a table followed by the detailed analysis report.

Strengths	Weaknesses
1. CSL’s well-established market leadership gives it a significant competitive edge 2. Well diverse performing product portfolio boosts profitability 3. A strong focus on research and development fuels the company’s sustainable growth 4. Globally acknowledged leading innovation of Seqirus will strengthen its market position 5. Building efficiency and scale of its operations to supply the expanding global market will boost its market share	1. Heavy reliance on plasma supply can impact business operations 2. Complex manufacturing processes may lead to supply chain issues.
Opportunities	Threats
1. The evolving influenza vaccine market will boost CSL’s product sales 2. Expanding immunoglobin market will enable CSL to drive high growth 3. Global collaborations for innovation will strengthen its product portfolio 4. Strategic acquisitions to drive growth in the therapeutic business segment will help CSL reach a larger patient base	1. Strong competition from pharmaceutical and biotechnology companies can impact profitability 2. Privacy and cybersecurity issues related to patient, donor, and employee data can severely impact a company's reputation.

Sample Complete Report

This is the sample complete report which will give you a glimpse of what your complete report will cover after purchase.

Free Summary Report

This report contains the table contents only. In case you need the complete report please purchase using the buy options displayed.

* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."

SWOT & PESTLE (combined)
Complete Report
USD 19.53

Debit/Credit card
PayPal

Great quality, Affordable pricing.

Safe and secure payments

On purchase the CSL Limited SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.

Detailed SWOT Analysis of CSL Limited (Commonwealth Serum Laboratories)

Strength

This section is available only in the 'Complete Report' on purchase.

Weakness

This section is available only in the 'Complete Report' on purchase.

Opportunity

This section is available only in the 'Complete Report' on purchase.

Threats

1. Strong competition from pharmaceutical and biotechnology companies can impact profitability: CSL faces a formidable challenge from pharmaceutical and biotechnology companies, which may affect the company's profitability. The biopharmaceutical sector is very competitive, distinguished by quick invention, substantial R&D, and an ongoing rush to provide novel treatments to the market. Because of this, CSL is under constant pressure to make R&D investments to remain at the forefront of scientific developments. The market is also progressively evolving as a result of mergers and acquisitions (M&A), with some of the biggest pharmaceutical corporations strengthening their positions by forming alliances with or being acquired by other companies. In the next five years, another 17 products—which presently generate over US$145 billion in annual sales—will lose their patent protection and give way to more affordable competitors for market share, according to an analysis by EY. To combat this, CSL needs to continue emphasizing innovation-based distinction, maintain operational effectiveness, and consistently showcase the higher caliber and efficacy of its products. CSL can also benefit from strategic alliances and collaborations to assist it in navigating the competitive environment.

The remaining section of “Threat” is available only in the 'Complete Report' on purchase.

The PESTLE / PESTEL analysis for CSL Limited is presented below in a table followed by the detailed analysis report.

Political	Economical
1. The Australian government’s increasing support of biosimilar medicines will impact CSL’s product line 2. The Australian government’s scheme to provide twice the medication for the cost of one prescription will pressure CSL’s supply chain	1. Foreign exchange and interest rate fluctuations will impact CSL’s operational costs 2. Raw material shortage and price hikes will impact CSL’s production costs
Social	Technological
1. Increased use of telehealth services will allow CSL to reach a larger patient base 2. Consumers increasingly opting for personalized medicine will influence the company’s product portfolio	1. Leveraging data science to strengthen its R&D and optimizing its processes to positively impact the business 2. Use of artificial intelligence for better efficiency and growth 3. A strong focus on digitalization will provide a competitive advantage
Legal	Environmental
1. A lawsuit against CSL Group for gender discrimination can damage its reputation. 2. Compliance with patient safety and product quality will impact operational costs 3. Changing Global laws and regulations in the healthcare industry will severely impact CSL’s supply chain.	1. A strong focus on environmental sustainability will positively impact CSL’s brand reputation 2. CSL’s focus on reducing the amount of packaging materials used will optimize its operations

Sample Complete Report

This is the sample complete report which will give you a glimpse of what your complete report will cover after purchase.

Free Summary Report

This report contains the table contents only. In case you need the complete report please purchase using the buy options displayed.

* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."

SWOT & PESTLE (combined)
Complete Report
USD 19.53

Debit/Credit card
PayPal

Great quality, Affordable pricing.

Safe and secure payments

On purchase the CSL Limited SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.

Detailed Pestle Analysis of CSL Limited (Commonwealth Serum Laboratories)

Political

This section is available only in the 'Complete Report' on purchase.

Economic

This section is available only in the 'Complete Report' on purchase.

Social

This section is available only in the 'Complete Report' on purchase.

Technological

This section is available only in the 'Complete Report' on purchase.

Legal

1. Lawsuit against CSL Group for gender discrimination can damage its reputation: The reputation of CSL Group could be seriously harmed by a lawsuit alleging gender discrimination. The public's and investors' faith in the corporation may be damaged by such accusations. It calls into doubt the company's commitment to diversity, inclusiveness, and equal opportunity in addition to raising issues about the workplace culture. A lawsuit was filed against CSL Plasma for preventing a transgender woman and a non-binary Minnesotan from giving plasma. CSL Plasma broke Minnesota's civil rights statute by refusing to do business with transgenders and non-binary people because of their gender identification. Since then, CSL Plasma has established and implemented procedures outlining the circumstances under which a person may be refused the chance to donate plasma, emphasizing that no one may be refused based on their gender identity alone.

The remaining section of “Legal” is available only in the 'Complete Report' on purchase.

Environmental

This section is available only in the 'Complete Report' on purchase.

Major Competitors :

Fresenius
Grifols
Baxter
DaVita
Roche
Teleflex
Shire
Medtronc

Major Brands :

CSL Behring
CSL Plasma
Seqirus

Sample Complete Report

This is the sample complete report which will give you a glimpse of what your complete report will cover after purchase.

Free Summary Report

This report contains the table contents only. In case you need the complete report please purchase using the buy options displayed.

* By clicking on "Buy Now" you agree to accept our "Terms and Conditions."

SWOT & PESTLE (combined)
Complete Report
USD 19.53

Debit/Credit card
PayPal

Great quality, Affordable pricing.

Safe and secure payments

On purchase the CSL Limited SWOT and PESTLE Analysis PDF report will reach you within minutes. At rare times, a slight delay not exceeding 1 hour might be caused.

DELIVERY AND FORMAT

WHY CHOOSE US?

You may also be interested in other analyses of CSL Limited (Commonwealth Serum Laboratories):

CSL Limited (Commonwealth Serum Laboratories) Porter's Five Forces Analysis
CSL Limited (Commonwealth Serum Laboratories) VRIO Analysis
CSL Limited (Commonwealth Serum Laboratories) Value Chain Analysis
CSL Limited (Commonwealth Serum Laboratories) Covid-19 Impact Analysis
CSL Limited (Commonwealth Serum Laboratories) BCG Analysis
CSL Limited (Commonwealth Serum Laboratories) Segmentation, Targeting and Positioning (STP) Analysis
CSL Limited (Commonwealth Serum Laboratories) Ansoff Matrix Analysis

Request for Quotation

CSL Limited (Commonwealth Serum Laboratories)

Comprehensive Library Of Research Reports

CSL Limited SWOT and PESTLE Analysis

COMPANY PROFILE -CSL Limited (Commonwealth Serum Laboratories)

Business Sector :Biotechnology

Operating Geography :Australia, Global

About CSL Limited (Commonwealth Serum Laboratories) :

CSL Limited (Commonwealth Serum Laboratories) Revenue :

Competitive Analysis of CSL Limited (Commonwealth Serum Laboratories)

Detailed SWOT Analysis of CSL Limited (Commonwealth Serum Laboratories)

Strength

Weakness

Opportunity

Threats

Detailed Pestle Analysis of CSL Limited (Commonwealth Serum Laboratories)

Political

Economic

Social

Technological

Legal

Environmental

Major Competitors :

Major Brands :

TABLE OF CONTENTS

DELIVERY AND FORMAT

WHY CHOOSE US?

You may also be interested in other analyses of CSL Limited (Commonwealth Serum Laboratories):

Check Out Analysis of Other Relevant Companies

References used in CSL Limited (Commonwealth Serum Laboratories) SWOT & PESTLE Analysis Report

How to Reference This Page?

Copyrights and Disclaimer

ORDER A CUSTOM REPORT

Other Companies in Pharmaceuticals in Australia & NZ

Other Companies in Pharmaceuticals

Other Companies in Australia & NZ

ADVERTISE WITH US

CSL Limited SWOT and PESTLE Analysis

TESTIMONIALS

ORDER A CUSTOM REPORT

ADVERTISE WITH US